{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:13:47Z","timestamp":1788480827872,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00228-021-03246-2","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T07:03:25Z","timestamp":1638428605000},"page":"405-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder"],"prefix":"10.1007","volume":"78","author":[{"given":"Yan-Nan","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Xi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-7367","authenticated-orcid":false,"given":"Can-Jun","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"10265","key":"3246_CR1","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","volume":"396","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Berk M, Brietzke E, Goldstein BI, Lopez-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB (2020) Bipolar disorders. Lancet 396(10265):1841\u20131856. https:\/\/doi.org\/10.1016\/S0140-6736(20)31544-0","journal-title":"Lancet"},{"key":"3246_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neubiorev.2020.12.031","volume":"122","author":"MJ Rantala","year":"2021","unstructured":"Rantala MJ, Luoto S, Borraz-Leon JI, Krams I (2021) Bipolar disorder: An evolutionary psychoneuroimmunological approach. Neurosci Biobehav Rev 122:28\u201337. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.12.031","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"3246_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","volume":"3","author":"D Vigo","year":"2016","unstructured":"Vigo D, Thornicroft G, Atun R (2016) Estimating the true global burden of mental illness. Lancet Psychiatry 3(2):171\u2013178. https:\/\/doi.org\/10.1016\/S2215-0366(15)00505-2","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"3246_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241\u2013251. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.12","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"3246_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","volume":"5","author":"CL Bowden","year":"2003","unstructured":"Bowden CL (2003) Valproate. Bipolar Disord 5(3):189\u2013202. https:\/\/doi.org\/10.1034\/j.1399-5618.2003.00031.x","journal-title":"Bipolar Disord"},{"issue":"6","key":"3246_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/01.WNF.0000228209.69524.E8","volume":"29","author":"J Fleming","year":"2006","unstructured":"Fleming J, Chetty M (2006) Therapeutic monitoring of valproate in psychiatry: how far have we progressed? Clin Neuropharmacol 29(6):350\u2013360. https:\/\/doi.org\/10.1097\/01.WNF.0000228209.69524.E8","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"3246_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","volume":"24","author":"RJ Baldessarini","year":"2019","unstructured":"Baldessarini RJ, Tondo L, Vazquez GH (2019) Pharmacological treatment of adult bipolar disorder. Mol Psychiatry 24(2):198\u2013217. https:\/\/doi.org\/10.1038\/s41380-018-0044-2","journal-title":"Mol Psychiatry"},{"key":"3246_CR8","doi-asserted-by":"publisher","first-page":"D4052","DOI":"10.1002\/14651858.CD004052","volume":"1","author":"K Macritchie","year":"2003","unstructured":"Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G (2003) Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 1:D4052. https:\/\/doi.org\/10.1002\/14651858.CD004052","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3246_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O\u2019Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 20(2):97\u2013170. https:\/\/doi.org\/10.1111\/bdi.12609","journal-title":"Bipolar Disord"},{"issue":"2","key":"3246_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1176\/appi.ajp.163.2.272","volume":"163","author":"MH Allen","year":"2006","unstructured":"Allen MH, Hirschfeld RM, Wozniak PJ, Baker JD, Bowden CL (2006) Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 163(2):272\u2013275. https:\/\/doi.org\/10.1176\/appi.ajp.163.2.272","journal-title":"Am J Psychiatry"},{"issue":"1\u201302","key":"3246_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Grunder G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mossner R, Muller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P (2018) Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. Pharmacopsychiatry 51(1\u201302):9\u201362. https:\/\/doi.org\/10.1055\/s-0043-116492","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"3246_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/FTD.0000000000000100","volume":"37","author":"WW Lin","year":"2015","unstructured":"Lin WW, Jiao Z, Wang CL, Wang HY, Ma CL, Huang PF, Guo XZ, Liu YW (2015) Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen. Ther Drug Monit 37(1):76\u201383. https:\/\/doi.org\/10.1097\/FTD.0000000000000100","journal-title":"Ther Drug Monit"},{"key":"3246_CR13","doi-asserted-by":"publisher","unstructured":"Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HJ, Chou JC, Keck PJ, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57(5): 481\u2013489. https:\/\/doi.org\/10.1001\/archpsyc.57.5.481","DOI":"10.1001\/archpsyc.57.5.481"},{"issue":"6","key":"3246_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1176\/ajp.153.6.765","volume":"153","author":"CL Bowden","year":"1996","unstructured":"Bowden CL, Janicak PG, Orsulak P, Swann AC, Davis JM, Calabrese JR, Goodnick P, Small JG, Rush AJ, Kimmel SE, Risch SC, Morris DD (1996) Relation of serum valproate concentration to response in mania. Am J Psychiatry 153(6):765\u2013770. https:\/\/doi.org\/10.1176\/ajp.153.6.765","journal-title":"Am J Psychiatry"},{"issue":"8","key":"3246_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2165\/11634080-000000000-00000","volume":"51","author":"TK Kiang","year":"2012","unstructured":"Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH (2012) Fundamentals of population pharmacokinetic modelling: modelling and software. Clin Pharmacokinet 51(8):515\u2013525. https:\/\/doi.org\/10.2165\/11634080-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"3246_CR16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00228-020-02873-5","volume":"76","author":"A Abdulla","year":"2020","unstructured":"Abdulla A, Rogouti O, Hunfeld N, Endeman H, Dijkstra A, van Gelder T, Muller AE, de Winter B, Koch B (2020) Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients. Eur J Clin Pharmacol 76(7):957\u2013967. https:\/\/doi.org\/10.1007\/s00228-020-02873-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"3246_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/j.1552-4604.1997.tb04301.x","volume":"37","author":"E Yukawa","year":"1997","unstructured":"Yukawa E, To H, Ohdo S, Higuchi S, Aoyama T (1997) Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics. J Clin Pharmacol 37(12):1160\u20131167. https:\/\/doi.org\/10.1002\/j.1552-4604.1997.tb04301.x","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"3246_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(sici)1099-081x(199907)20:5<233::aid-bdd179>3.0.co;2-5","volume":"20","author":"B Blanco-Serrano","year":"1999","unstructured":"Blanco-Serrano B, Otero MJ, Santos-Buelga D, Garc\u00eda-S\u00e1nchez MJ, Serrano J, Dom\u00ednguez-Gil A (1999) Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data. Biopharm Drug Dispos 20(5):233\u2013240. https:\/\/doi.org\/10.1002\/(sici)1099-081x(199907)20:5%3c233::aid-bdd179%3e3.0.co;2-5","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"3246_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1046\/j.1365-2710.2003.00528.x","volume":"28","author":"E Yukawa","year":"2003","unstructured":"Yukawa E, Nonaka T, Yukawa M, Higuchi S, Kuroda T, Goto Y (2003) Pharmacoepidemiologic investigation of a clonazepam-valproic acid interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients. J Clin Pharm Ther 28(6):497\u2013504. https:\/\/doi.org\/10.1046\/j.1365-2710.2003.00528.x","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"3246_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1358\/mf.2007.29.10.1116313","volume":"29","author":"SM Jankovic","year":"2007","unstructured":"Jankovic SM, Milovanovic JR (2007) Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients. Methods Find Exp Clin Pharmacol 29(10):673\u2013679. https:\/\/doi.org\/10.1358\/mf.2007.29.10.1116313","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"5","key":"3246_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ejps.2009.09.017","volume":"38","author":"K Vuci\u0107evi\u0107","year":"2009","unstructured":"Vuci\u0107evi\u0107 K, Miljkovi\u0107 B, Pokrajac M, Prostran M, Martinovi\u0107 Z, Grabnar I (2009) The influence of drug-drug interaction and patients\u2019 characteristics on valproic acid\u2019s clearance in adults with epilepsy using nonlinear mixed effects modeling. Eur J Pharm Sci 38(5):512\u2013518. https:\/\/doi.org\/10.1016\/j.ejps.2009.09.017","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"3246_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.5414\/cpp48767","volume":"48","author":"SM Jankovic","year":"2010","unstructured":"Jankovic SM, Milovanovic JR, Jankovic S (2010) Factors influencing valproate pharmacokinetics in children and adults. Int J Clin Pharmacol Ther 48(11):767\u2013775. https:\/\/doi.org\/10.5414\/cpp48767","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"3246_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10928-013-9323-3","volume":"40","author":"M Ibarra","year":"2013","unstructured":"Ibarra M, V\u00e1zquez M, Fagiolino P, Derendorf H (2013) Sex related differences on valproic acid pharmacokinetics after oral single dose. J Pharmacokinet Pharmacodyn 40(4):479\u2013486. https:\/\/doi.org\/10.1007\/s10928-013-9323-3","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"11","key":"3246_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111066","volume":"9","author":"N Ogusu","year":"2014","unstructured":"Ogusu N, Saruwatari J, Nakashima H, Noai M, Nishimura M, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagaswa K (2014) Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of \u03b3-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis. PLoS ONE 9(11):e111066. https:\/\/doi.org\/10.1371\/journal.pone.0111066","journal-title":"PLoS ONE"},{"issue":"4","key":"3246_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s11096-019-00864-w","volume":"41","author":"S Alqahtani","year":"2019","unstructured":"Alqahtani S, Alandas N, Alsultan A (2019) Estimation of apparent clearance of valproic acid in adult Saudi patients. Int J Clin Pharm 41(4):1056\u20131061. https:\/\/doi.org\/10.1007\/s11096-019-00864-w","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"3246_CR26","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1007\/s11095-006-9067-5","volume":"23","author":"K Brendel","year":"2006","unstructured":"Brendel K, Comets E, Laffont C, Laveille C, Mentre F (2006) Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide. Pharm Res 23(9):2036\u20132049. https:\/\/doi.org\/10.1007\/s11095-006-9067-5","journal-title":"Pharm Res"},{"issue":"2","key":"3246_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets E, Brendel K, Mentre F (2008) Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Programs Biomed 90(2):154\u2013166. https:\/\/doi.org\/10.1016\/j.cmpb.2007.12.002","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"3246_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/jac\/dkq449","volume":"66","author":"JA Roberts","year":"2011","unstructured":"Roberts JA, Kirkpatrick CM, Lipman J (2011) Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients. J Antimicrob Chemother 66(2):227\u2013231. https:\/\/doi.org\/10.1093\/jac\/dkq449","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3246_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00007691-200306000-00005","volume":"25","author":"Z Jiao","year":"2003","unstructured":"Jiao Z, Zhong MK, Shi XJ, Hu M, Zhang JH (2003) Population pharmacokinetics of carbamazepine in Chinese epilepsy patients. Ther Drug Monit 25(3):279\u2013286. https:\/\/doi.org\/10.1097\/00007691-200306000-00005","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3246_CR30","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/j.1365-2125.2012.04406.x","volume":"75","author":"W Zhao","year":"2013","unstructured":"Zhao W, Kaguelidou F, Biran V, Zhang D, Allegaert K, Capparelli EV, Holford N, Kimura T, Lo YL, Peris JE, Thomson A, van den Anker JN, Fakhoury M, Jacqz-Aigrain E (2013) External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings. Br J Clin Pharmacol 75(4):1068\u20131080. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04406.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3246_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/bcp.12830","volume":"81","author":"CY Zhao","year":"2016","unstructured":"Zhao CY, Jiao Z, Mao JJ, Qiu XY (2016) External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients. Br J Clin Pharmacol 81(5):891\u2013907. https:\/\/doi.org\/10.1111\/bcp.12830","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3246_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/FTD.0b013e31811f3296","volume":"29","author":"AK Birnbaum","year":"2007","unstructured":"Birnbaum AK, Ahn JE, Brundage RC, Hardie NA, Conway JM, Leppik IE (2007) Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents. Ther Drug Monit 29(5):571\u2013575. https:\/\/doi.org\/10.1097\/FTD.0b013e31811f3296","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3246_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.clinthera.2017.04.005","volume":"39","author":"J Methaneethorn","year":"2017","unstructured":"Methaneethorn J (2017) Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens. Clin Ther 39(6):1171\u20131181. https:\/\/doi.org\/10.1016\/j.clinthera.2017.04.005","journal-title":"Clin Ther"},{"issue":"8","key":"3246_CR34","doi-asserted-by":"publisher","first-page":"1220751833","DOI":"10.1177\/0300060520952281","volume":"48","author":"J Guo","year":"2020","unstructured":"Guo J, Huo Y, Li F, Li Y, Guo Z, Han H, Zhou Y (2020) Impact of gender, albumin, and CYP2C19 polymorphisms on valproic acid in Chinese patients: a population pharmacokinetic model. J Int Med Res 48(8):1220751833. https:\/\/doi.org\/10.1177\/0300060520952281","journal-title":"J Int Med Res"},{"issue":"8","key":"3246_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00228-018-2440-6","volume":"74","author":"S Mei","year":"2018","unstructured":"Mei S, Feng W, Zhu L, Li X, Yu Y, Yang W, Gao B, Wu X, Fang F, Zhao Z (2018) Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model. Eur J Clin Pharmacol 74(8):1029\u20131036. https:\/\/doi.org\/10.1007\/s00228-018-2440-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3246_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"J Methaneethorn","year":"2018","unstructured":"Methaneethorn J (2018) A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol 84(5):816\u2013834. https:\/\/doi.org\/10.1111\/bcp.13510","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3246_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Y Ghodke-Puranik","year":"2013","unstructured":"Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, Altman RB, Klein TE (2013) Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics 23(4):236\u2013241. https:\/\/doi.org\/10.1097\/FPC.0b013e32835ea0b2","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"3246_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3349\/ymj.2014.55.1.232","volume":"55","author":"JY Kim","year":"2014","unstructured":"Kim JY, Cheong HS, Park BL, Kim LH, Namgoong S, Kim JO, Kim HD, Kim YH, Chung MW, Han SY, Shin HD (2014) Comprehensive variant screening of the UGT gene family. Yonsei Med J 55(1):232\u2013239. https:\/\/doi.org\/10.3349\/ymj.2014.55.1.232","journal-title":"Yonsei Med J"},{"issue":"2","key":"3246_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/tpj.2015.70","volume":"16","author":"I Fricke-Galindo","year":"2016","unstructured":"Fricke-Galindo I, C\u00e9spedes-Garro C, Rodrigues-Soares F, Naranjo ME, Delgado \u00c1, de Andr\u00e9s F, L\u00f3pez-L\u00f3pez M, Pe\u00f1as-Lled\u00f3 E, LLerena A, (2016) Interethnic variation of CYP2C19 alleles, \u201cpredicted\u201d phenotypes and \u201cmeasured\u201d metabolic phenotypes across world populations. Pharmacogenomics J 16(2):113\u2013123. https:\/\/doi.org\/10.1038\/tpj.2015.70","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"3246_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF03256440","volume":"10","author":"E Garc\u00eda-Mart\u00edn","year":"2006","unstructured":"Garc\u00eda-Mart\u00edn E, Mart\u00ednez C, Ladero JM, Ag\u00fandez JA (2006) Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. Mol Diagn Ther 10(1):29\u201340. https:\/\/doi.org\/10.1007\/BF03256440","journal-title":"Mol Diagn Ther"},{"key":"3246_CR41","doi-asserted-by":"publisher","unstructured":"Dorji PW, Wangchuk S, Boonprasert K, Tarasuk M, Na-Bangchang K (2019) Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population. Drug Metab Pers Ther 34(4):\/j\/dmdi.2019.34.issue-4\/dmpt-2019\u20130020\/dmpt-2019\u20130020.xml. https:\/\/doi.org\/10.1515\/dmpt-2019-0020","DOI":"10.1515\/dmpt-2019-0020"},{"issue":"12","key":"3246_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00228-009-0712-x","volume":"65","author":"D Jiang","year":"2009","unstructured":"Jiang D, Bai X, Zhang Q, Lu W, Wang Y, Li L, M\u00fcller M (2009) Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling. Eur J Clin Pharmacol 65(12):1187\u20131193. https:\/\/doi.org\/10.1007\/s00228-009-0712-x","journal-title":"Eur J Clin Pharmacol"},{"key":"3246_CR43","doi-asserted-by":"publisher","unstructured":"Du Z, Jiao Y, Shi L (2016) Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children. Med Sci Monit 22:4107\u20134113. https:\/\/doi.org\/10.12659\/msm.897626","DOI":"10.12659\/msm.897626"},{"key":"3246_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eplepsyres.2015.04.015","volume":"114","author":"YX Sun","year":"2015","unstructured":"Sun YX, Zhuo WY, Lin H, Peng ZK, Wang HM, Huang HW, Luo YH, Tang FQ (2015) The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients. Epilepsy Res 114:78\u201380. https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.04.015","journal-title":"Epilepsy Res"},{"issue":"4","key":"3246_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00228-017-2395-z","volume":"74","author":"P Wang","year":"2018","unstructured":"Wang P, Lin XQ, Cai WK, Xu GL, Zhou MD, Yang M, He GH (2018) Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis. Eur J Clin Pharmacol 74(4):433\u2013442. https:\/\/doi.org\/10.1007\/s00228-017-2395-z","journal-title":"Eur J Clin Pharmacol"},{"key":"3246_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/542862","volume":"2015","author":"J Jackson","year":"2015","unstructured":"Jackson J, McCollum B, Ognibene J, Diaz FJ, de Leon J (2015) Three patients needing high doses of valproic Acid to get therapeutic concentrations. Case Rep Psychiatry 2015:542862. https:\/\/doi.org\/10.1155\/2015\/542862","journal-title":"Case Rep Psychiatry"},{"issue":"1\u20132","key":"3246_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","volume":"377","author":"A Dasgupta","year":"2007","unstructured":"Dasgupta A (2007) Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management. Clin Chim Acta 377(1\u20132):1\u201313. https:\/\/doi.org\/10.1016\/j.cca.2006.08.026","journal-title":"Clin Chim Acta"},{"key":"3246_CR48","doi-asserted-by":"publisher","unstructured":"Xikun W, Haoran L, Weichong D, Xiuling Y, Yiran J, Ying G, Zhiqing Z, Xiujv L (2021) Determination of free valproic acid concentration in 569 clinical samples by LC-MS\/MS after HFCF-UF treatment. Ther Drug Monit. Epub ahead of print. https:\/\/doi.org\/10.1097\/FTD.0000000000000903","DOI":"10.1097\/FTD.0000000000000903"},{"issue":"7","key":"3246_CR49","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E (2008) Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies Epilepsia 49(7):1239\u20131276. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01561.x","journal-title":"ILAE Commission on Therapeutic Strategies Epilepsia"},{"issue":"11","key":"3246_CR50","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1176\/ajp.2006.163.11.1891","volume":"163","author":"NB Sandson","year":"2006","unstructured":"Sandson NB, Marcucci C, Bourke DL, Smith-Lamacchia R (2006) An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions. Am J Psychiatry 163(11):1891\u20131896. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1891","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3246_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.psym.2018.07.009","volume":"60","author":"CJ Ruan","year":"2019","unstructured":"Ruan CJ, de Leon J (2019) Thirty Years of Both Ignorance and Clinical Experience Suggest That Clozapine Intoxication During Co-Occurring Infections and Inflammation May Have Higher Morbidity and Mortality Than Is Currently Believed. Psychosomatics 60(2):221\u2013222. https:\/\/doi.org\/10.1016\/j.psym.2018.07.009","journal-title":"Psychosomatics"},{"key":"3246_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","volume":"83","author":"GD Anderson","year":"2008","unstructured":"Anderson GD (2008) Gender differences in pharmacological response. Int Rev Neurobiol 83:1\u201310. https:\/\/doi.org\/10.1016\/S0074-7742(08)00001-9","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"3246_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/03602530903209288","volume":"42","author":"MH Court","year":"2010","unstructured":"Court MH (2010) Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 42(1):209\u2013224. https:\/\/doi.org\/10.3109\/03602530903209288","journal-title":"Drug Metab Rev"},{"issue":"2","key":"3246_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.phrs.2006.11.001","volume":"55","author":"F Franconi","year":"2007","unstructured":"Franconi F, Brunelleschi S, Steardo L, Cuomo V (2007) Gender differences in drug responses. Pharmacol Res 55(2):81\u201395. https:\/\/doi.org\/10.1016\/j.phrs.2006.11.001","journal-title":"Pharmacol Res"},{"issue":"4","key":"3246_CR55","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00007691-200208000-00012","volume":"24","author":"L Wang","year":"2002","unstructured":"Wang L, Wang XD (2002) Pharmacokinetic and pharmacodynamic effects of clonazepam in children with epilepsy treated with valproate: a preliminary study. Ther Drug Monit 24(4):532\u2013536. https:\/\/doi.org\/10.1097\/00007691-200208000-00012","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3246_CR56","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2165\/00003495-198224060-00004","volume":"24","author":"RH Levy","year":"1982","unstructured":"Levy RH, Koch KM (1982) Drug interactions with valproic acid. Drugs 24(6):543\u2013556. https:\/\/doi.org\/10.2165\/00003495-198224060-00004","journal-title":"Drugs"},{"issue":"8","key":"3246_CR57","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/00004583-200108000-00003","volume":"40","author":"PJ van Wattum","year":"2001","unstructured":"van Wattum PJ (2001) Valproic acid and risperidone. J Am Acad Child Adolesc Psychiatry 40(8):866\u2013867. https:\/\/doi.org\/10.1097\/00004583-200108000-00003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"3246_CR58","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00004583-200206000-00002","volume":"41","author":"M Bertoldo","year":"2002","unstructured":"Bertoldo M (2002) Valproic acid and risperidone. J Am Acad Child Adolesc Psychiatry 41(6):632. https:\/\/doi.org\/10.1097\/00004583-200206000-00002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"3246_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00004583-200301000-00001","volume":"42","author":"JK Sund","year":"2003","unstructured":"Sund JK, Aamo T, Spigset O (2003) Valproic acid and risperidone: a drug interaction? J Am Acad Child Adolesc Psychiatry 42(1):1\u20132. https:\/\/doi.org\/10.1097\/00004583-200301000-00001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3246_CR60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2016.02.014","volume":"106","author":"E Spina","year":"2016","unstructured":"Spina E, Pisani F, de Leon J (2016) Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. Pharmacol Res 106:72\u201386. https:\/\/doi.org\/10.1016\/j.phrs.2016.02.014","journal-title":"Pharmacol Res"},{"issue":"2","key":"3246_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00002018-200629020-00001","volume":"29","author":"FM Besag","year":"2006","unstructured":"Besag FM, Berry D (2006) Interactions between antiepileptic and antipsychotic drugs. Drug Saf 29(2):95\u2013118. https:\/\/doi.org\/10.2165\/00002018-200629020-00001","journal-title":"Drug Saf"},{"issue":"4","key":"3246_CR62","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/13651509909068397","volume":"3","author":"T Berigan","year":"1999","unstructured":"Berigan T, Harazin J (1999) A sertraline\/valproic acid drug interaction: Case Reports. Int J Psychiatry Clin Pract 3(4):287\u2013288. https:\/\/doi.org\/10.3109\/13651509909068397","journal-title":"Int J Psychiatry Clin Pract"},{"key":"3246_CR63","doi-asserted-by":"publisher","unstructured":"Cloyd JC, Fischer JH, Kriel RL, Kraus DM (1993) Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin Pharmacol Ther 53(1):22\u201329. https:\/\/doi.org\/10.1038\/clpt.1993.5","DOI":"10.1038\/clpt.1993.5"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03246-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03246-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03246-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T04:16:37Z","timestamp":1644207397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03246-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03246-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"17 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for the study was approved by the Research Ethics Committee of Beijing Anding Hospital (ethical code: 201965FS-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}